John Overdeck’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

John Overdeck’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-94,042	Closed	-$627K	–	3452
2023 Q3	$627K	Sell	94,042 -370,585	-80%	-$3.08M	﹤0.01%	2179
2023 Q2	$4.21M	Buy	464,627 +304,665	+190%	+$2.69M	0.01%	1006
2023 Q1	$1.16M	Buy	159,962 +135,362	+550%	+$1M	﹤0.01%	1787
2022 Q4	$179K	Buy	+24,600	New	+$183K	﹤0.01%	2414

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

John Overdeck's PNT Position: Q4 2023 in Review

John Overdeck sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 94,042 shares — an estimated $627K sold.

John Overdeck first reported a position in PNT in Q4 2022 and held it in 4 quarters. The position peaked at $4.21M in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

John Overdeck reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
John Overdeck sold 94,042 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $627K.
John Overdeck first reported a position in POINT Biopharma Global Inc. Common Stock in Q4 2022 and held it in 4 quarters.
John Overdeck's POINT Biopharma Global Inc. Common Stock position peaked at $4.21M in Q2 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Two Sigma Investments's 13F filing for Q4 2023, filed 14 Feb 2024.